Nothing particularly inspiring in terms of timelines in this update yet hopefully the new sales HC can begin to close some deals very soon.
Running a very simple cash flow model using simple assumptions suggest Anteo (once again) don't have very long.
Revenue growth of 25%, perhaps ambitious given Q1/Q2 was flat, before growing 40% period on period.
Assume that operating costs increase by 10% each quarter going forward.
From the CF statement, there is a high ratio of R&D to Production Costs. Assumably revenue is coming from services rather than product, or from sales of goods produced in the R&D streams (ie customer specific trials such as an Ultranode for MB). For simplicity, I have not estimated production costs and would hope the R&D/Production cost ratio flips over time.
No major CAPEX, which is highly unlikely if there is ramp up and they plan to harness the ARENA grant. They may avoid this CAPEX through OEM of product in geographies closer to their future customers.
Tough outlook in the absence of improved CF or another CR supported at a higher share price from news flow.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Tough outlook in the absence of improved CF or another CR supported at a higher share price from news flow.
(20min delay)